Lv3
214 积分 2023-12-18 加入
Synthetic lethality in MTAP-deleted tumors: a promising avenue through targeted disruption of the protein methylation pathway
9小时前
求助中
Combination of the MTA-Cooperative PRMT5 Inhibitor BMS-986504 and KRAS Inhibitors is an Effective Treatment Strategy for MTAP-Deleted KRAS-Mutant Pancreatic Cancer
7天前
已完结
The role of synthetic lethality in overcoming cancer therapy resistance: emerging paradigm and recent advances
11天前
已完结
Disrupted methionine cycle triggers muscle atrophy in cancer cachexia through epigenetic regulation of REDD1
1个月前
已完结
Manuscript Preparation for Submission and Publication
2个月前
已完结
Epidemiology, pathogenesis, biology and evolving management of MSI-H/dMMR cancers
2个月前
已完结
Long-chain sulfatide enrichment is an actionable metabolic vulnerability in intraductal papillary mucinous neoplasm (IPMN)-associated pancreatic cancers
4个月前
已关闭
Metabolites are not genes — avoiding the misuse of pathway analysis in metabolomics
4个月前
已完结
Targeting MXD1 sensitises pancreatic cancer to trametinib
7个月前
已完结
Tumour Cell Heterogeneity Instructs Fibroblast Diversity and Reciprocal Signalling
8个月前
已完结
皖公网安备34019202002308
